Violation of Carbohydrate Metabolism in Patients with  Covid-19

Sadikova N.  G.; Urunbayeva D.  A.; Najmutdinova D.  K.; Tojimatova G.  M.

Sadikova N. G. Associate professor at Tashkent Medical Academy, Tashkent, Uzbekistan
Urunbayeva D. A. Associate professor at Tashkent Medical Academy, Tashkent, Uzbekistan
Najmutdinova D. K. Professor at Tashkent Medical Academy, Tashkent, Uzbekistan
Tojimatova G. M. Master student at Tashkent Medical Academy, Tashkent, Uzbekistan

Keywords: COVID-19, SARS-CoV2, diabetes, carbohydrate metabolism disorder, glycated hemoglobin

Abstract

“Covid-19” infection, one of the most urgent problems of the 21st century, was first detected in December 2019 in Wuhan, China, and was declared a pandemic by the World Health Organization on March 11, 2020. According to the WHO, the elderly patients with concomitant diseases dominate the structure of infection with the new coronavirus. Cardiovascular system diseases, diabetes mellitus (DM), obesity, and chronic diseases are the most common among concomitant diseases. It is known that the main target organs of the SARS-CoV2 are the mucous membranes of the respiratory tract and the gastrointestinal tract. However, the virus uses ACE2 receptors to enter the cell, and this receptor is present not only in the lungs, but also in many other tissues and organs, including the exocrine part of the pancreas and the islets of Langerhans.

References

1. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. Brussels, Belgium: International Diabetes Federation, 2015. [cited 29 march 2020] Available from: http://www.idf.org/ diabetes atlas.
2. World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19–11. March 2020 [Internet] 2020. Available from: https://www.who.int/director-general/speeches/ detail/who-director-general-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020
3. Маркова Т.Н., Лысенко М.А., Пономарева А.А., Иванова А.А., Павлова Е.С., Чибисова В.В., Исаев Т.К., Синявкин Д.О., Мкртумян А.М. Распространенность нарушений углеводного обмена у пациентов с новой коронавирусной инфекцией // Сахарный диабет. — 2021. — Т. 24. — №3. — С. 222-230. doi: https://doi.org/10.14341/DM12712
4. Yan Y, Yang Y, Wang F, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care. 2020;8(1):e001343. doi: https://doi.org/10.1136/bmjdrc-2020-001343
5. MacIntyre EJ, Majumdar SR, Gamble JM, et al. Stress hyperglycemia and newly diagnosed diabetes in 2124 patients hospitalized with pneumonia. Am J Med.2012;125(10):1036.e17-23.doi: https://doi.org/10.1016/j.amjmed.2012.01.026
6. Ilias I, Jahaj E, Kokkoris S, et al. Clinical Study of Hyperglycemia and SARS-CoV-2 Infection in Intensive Care Unit Patients. In Vivo. 2020;34(5):3029-3032. doi: https://doi.org/10.21873/invivo.12136Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. doi: https://doi.org/10.1016/S0140-6736(20)30183-5
7. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. doi: https://doi.org/10.1016/S0140-6736(20)30566-3
8. Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication. https://www.mcponline.org/article/S1535-9476(21)00131-6/fulltext#%20